Coronary/Structural Heart

DalCor announces dal-GenE trial to continue as planned following interim futility analysis

LONDON and MONTREAL, Jan. 27, 2020 (GLOBE NEWSWIRE) — DalCor Pharmaceuticals today announced that following the results of the interim futility analysis of the dalcetrapib dal-GenE Phase 3 trial, DalCor will continue the dal-GenE trial as recommended by the independent Data and Safety Monitoring Board (DSMB). “We are pleased to […]

Neovasc Advances New Transfemoral Trans-septal Tiara Design Concept After Further Successful Tests

VANCOUVER, Jan. 24, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that after further successful acute […]

CHF Solutions Announces Launch of Aquapheresis Therapy Using Aquadex FlexFlow® System at the Baylor Scott & White Health System in Texas

EDEN PRAIRIE, Minn., Jan. 22, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced that Texas-based health system, Baylor Scott & White Health has initiated offering aquapheresis therapy using the company’s Aquadex FlexFlow® system at its Baylor Scott & White Medical Center in Temple, Texas. “Fluid overload continues to be […]

Renowned Cardiovascular Surgeons to Lead MemorialCare Heart & Vascular Institute, Offer Patients Least Invasive Heart Valve Surgery Breakthrough

ORANGE and LOS ANGELES Counties, Calif., Jan. 23, 2020 /PRNewswire/ — Nationally renowned cardiovascular surgeons Marc Sakwa, M.D. and Jeffrey Altshuler, M.D. are bringing their leadership, surgical advancements and world-class expertise in minimally invasive heart surgery for complex heart procedures to MemorialCare Heart & Vascular Institute, continuing the expansion and development of cardiovascular care services and the legacy […]

Teleflex Receives FDA Clearance for Wattson™ Temporary Pacing Guidewire

WAYNE, Pa., Jan. 22, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that it received 510(k) clearance from the U.S. Food and Drug Administration for the WattsonTM Temporary Pacing Guidewire – the first commercially available bipolar temporary […]

European Commission Grants BioVentrix CE Mark Extension for Revivent TC Less Invasive Ventricular Enhancement Therapy

SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., developer of the first transcatheter device for left ventricular remodeling after a heart attack, today announced the extension of its CE Mark for the Revivent TC™ Transcatheter Ventricular Enhancement System for heart failure to May 2024. “The extension of our CE Mark is not only an important […]

Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes

LEIDEN, the Netherlands & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ncardia and BlueRock Therapeutics today announced an agreement covering process development technologies for the manufacture of induced pluripotent stem cell (iPSC)-derived cardiomyocytes. Under the terms of the agreement, Bluerock gains access to Ncardia’s large-scale production processes and intellectual property for the production of iPSC-derived […]

First Study of Thoraguard Digital Drainage System Completed at Stanford University Medical Center

Latest Guidelines to Enhance Patient Recovery after Cardiac Surgery Strongly Recommend: Maintenance of Chest Tube Patency to Prevent Complications OMAHA, Neb.–(BUSINESS WIRE)–Centese, Inc. today announced completion of the first clinical study of its Thoraguard® digital drainage system used in cardiac surgery at Stanford University Medical Center. Thoraguard is the first surgical […]


For ImageGuide Users, ASNC and ASE members, QCDR Status Eases MIPS Reporting Burden Fairfax, VA (January 21, 2020) – The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) are pleased to announce that the Centers for Medicare and Medicaid Services have approved the ImageGuide Registry® […]

Novoheart Contracts with Global Pharma to Develop Novel Microplate for High Throughput Drug Screening Using Engineered Human Heart Tissue Strips

New 96-Well Microplates (hvCTS-96) to Further Advance MyHeart™ Platform Capabilities for High-throughput Screening of Compounds on Engineered Human Heart Tissue Strips Novoheart Partners with a Global Pharma to Design and Develop the New Microplate and Will Retain Full Ownership of All IP Novoheart is to Enter a Billion-dollar Market and Generate […]